2BB score and signals
Corvus Pharmaceuticals, Inc.’s current 2BB score is 46 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 68 | High |
| Momentum | 60 | Improving |
| Financial strength | 32 | Weak |
| Quality | 60 | Strong |
| Risk | 37 | Low |
Company facts
| Headquarters | Burlingame, California, United States |
| Founded | 2014 |
| Employees | 37 |
| 52-week range | $4.52 – $26.95 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-02 | — | -0.1964 | — | $0.00 |
| 2026-08-06 | — | -0.1619 | — | $0.00 |
| 2026-05-07 | -0.15 | -0.1457 | $0.00 | $0.00 |
| 2026-03-12 | -0.15 | -0.1319 | $0.00 | $0.00 |
Related companies
